期刊文献+

深圳市人民医院沙门菌对抗菌药物敏感性分析 被引量:2

Antimicrobial resistance in the Salmonella strains isolated from Shenzhen People's Hospital
下载PDF
导出
摘要 目的监测我院2002—2007年临床分离沙门菌对各类抗菌药物敏感性,指导临床合理使用抗菌药物。方法采用琼脂稀释法检测各类抗菌药物对95株沙门菌MIC,数据分析采用WHONET5.3软件。结果伤寒沙门菌和甲型副伤寒沙门菌对氨苄西林、氯霉素、复方磺胺甲口恶唑敏感率仍分别高达96%~100%和97%~100%,未发现多重耐药株(MDR);52%(13/25)伤寒沙门菌和94%(62/66)甲型副伤寒沙门菌对萘啶酸耐药,对环丙沙星敏感性降低(MIC=0.125~1mg/L)伤寒和甲型副伤寒沙门菌分别占24.0%(6/25)和92.4%(61/66);1株乙型副伤寒沙门菌和1株鼠伤寒沙门菌对环丙沙星等氟喹诺酮类药物高耐药(MIC≥16mg/L),且对氨苄西林、氯霉素和复方磺胺甲口恶唑多重耐药。结论我院环丙沙星敏感性降低伤寒和甲型副伤寒沙门菌较常见,出现高耐氟喹诺酮类药物且多重耐药的乙型副伤寒沙门菌和鼠伤寒沙门菌,应加强对沙门菌耐药性监测。 Objective To investigate the antimicrobial resistance among the Salmonella strains isolated from Shenzhen People's Hospital. Methods The minimal inhibitory concentrations (MICs) of antibacterial agents were determined by agar dilution meth od against 95 strains of Salmonella. WHONET 5.3 software was used to analyze the data. Results S. typhi and S. paratyphi A remained highly susceptible to ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole. About 96%-100% and 97%-100% of the strains were susceptible respectively. Multidrug-resistant isolate was not found. About 52% (13/25) of S. typhi isolates and 94% (62/66) of S. paratyphi A isolates were resistant to nalidixie acid, respectively. The prevalence of S. typhi and S. paratyphi A with decreased susceptibility to ciprofloxacin (MIC = 0. 125 -1 mg/L) was 24% (6/25) and 92.4% (61/ 66), respectively. One strain of S. paratyphi B and one strain of S. typhimurium showed high resistance to ciprofloxacin (MIC≥16 mg/L), and resistance to ampicillin, chloramphenicol and trimethoprim-sulfamethoxazole too. Conclusions The S. typhi and S. paratyphi A with decreased susceptibility to ciprofloxacin were prevalent in our hospital. Ciprofloxacin-resistant S. paratyphi B and S. typhimurium were identified.
出处 《中国感染与化疗杂志》 CAS 2008年第6期459-462,共4页 Chinese Journal of Infection and Chemotherapy
基金 广东省自然科学基金(5009113)
关键词 沙门菌 环丙沙星敏感性降低 多重耐药 Salmonella Decreased susceptibility to ciprofloxacin Multidrug resistance
  • 相关文献

参考文献13

  • 1Crump JA, Luby SP, Minlz ED. The global burden of ty phoid fever [J]. Bull World Health Organ, 2004, 82(5): 346-353.
  • 2Bhan MK. Bhal R, Bhalnagar S. Typhoid and paralyphoid fever [J]. Lancet. 2005. 366(9497): 749-762.
  • 3Saha SK, Darmstadt GL, Baqui AH, et al. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serowlr typhi in Bangladesh [J]. J Clin Microbiol, 2006. 44(10): 3811-3813.
  • 4Gaind R, Paglieui B, Murgla M. et al. Molecular characler ization of ciprofloxacin resistant Salmonella cnterica serovar Typhi and Paratyphi A causing enteric fever in India [J]. J Antimicrob (Themother . 2006, 58(6): 1139-1144.
  • 5Adachi T, Sagara H, Hirose K, et al. Huoroquinolone resistant Salmonella Paratyphi A [J]. Emerg Infect Dis, 2005, 11(1):172-174.
  • 6Hirose K, Tamura K, Sagara H, et al. Antibiotic suscepti- bililies of Salmonella enterica serovar typhi and S. enterica serovar paratyphi A isolated from patients in Japan [J]. An timicrob Agents Chemother, 2001, 45(3): 956-958.
  • 7Capoor MR, Nair D. Aggarwal P, et al. Salmonella enterica serovar typhi: molecular analysis of strains whh decreased susceptibility and resistanl to ciprofloxacin in India from 2001-2003 [J]. Braz J Infect Dis, 2007, 11(4): 423-425.
  • 8Chau TT, Campbell Jl, Galindo CM, et al. Antimicrobial drug resistance of salmonella enleriea serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones [J]. Antimicrob Agents Chemolher, 2007, 51 (12) : 4315 -4323.
  • 9Wain J, Hoa NT, Chinh NT, et al. Quinolone resistant Sal monella typhi in Viet Nam: molecular basis of resistance and clinical response to trealment [J]. Clin Infect Dis, 1997, 25 (6): 1404 1410.
  • 10Threlfall E J, Ward LR. Decreased susceptibilily to ciproflox acin in Salmonella entcrica serotype typhi, United Kingdom [J]. Emer Infect Dis, 2001, 7(3): 448-450.

同被引文献22

  • 1陈庆法,陈强,余晓君,周红平,柯江维,朱春晖,段荣.腹泻儿童沙门菌的耐药性研究及肠毒素基因与临床关系分析[J].中华临床医师杂志(电子版),2011,5(18):5360-5365. 被引量:16
  • 2陈晶,孙自镛.鼠伤寒沙门菌对喹诺酮类耐药机制的研究[J].中国感染与化疗杂志,2006,6(2):100-104. 被引量:11
  • 3Valdezate S, Vidal A, Herrera-Le6n S, et al. Salmonella derby clonal spread from pork[J]. Emerg Infect Dis, 2005, 11(5): 694-698.
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty- second Informational Supplement M100-S22[J]. CLSI, Wayne, PA, USA, 2012.
  • 5Sahilah A M, Son R, et al. molecular typing of Salmonella weltevreden and Salmonella chincol by pulsed-field gel electrophoresis (PFGE) and enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) [J]. WorldJMicrobiol Biotechnol, 2000, 16(7): 621-624.
  • 6Wang M, Guo Q, Xu X, et al. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis[J]. Antimicrob Agents Chemother, 2009,53(5):1892-1897.
  • 7Cavaco L M, Hasman H, Xia S, et al. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin[J]. Antimicrob Agents Chemother, 2009, 53(2): 603-608.
  • 8Robicsek A, Strahilevitz J, Jacoby G A, et al. Fluoroquinolone modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase[J]. Nat Med, 2006, 12(1): 83-88.
  • 9Lomovskaya O, Warren M S, Lee A, et al. Identification and characterization of inhibitors of multidrug resistance effiux pumps in Pseudomonas aeruginosa: novel agents for combination therapy[J]. Antimicrob Agents Chemother,2001,45(1):105-116.
  • 10Jones-Dias D, Manageiro V, Francisco A P, et al. Assessing themolecular basis of transferable quinolone resistance in Escherichia coli and Salmonella spp. from food-producing animals and food products[J]. Veter Microbiol, 2013, 167(3- 4): 523-531.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部